Citius Oncology (CTOR) Receivables - Net (2025 - 2026)

Citius Oncology's (CTOR) quarterly Receivables - Net came in at $1.1 million in Q1 2026, down 73.35% on a QoQ basis from $4.0 million in Q4 2025.

Citius Oncology (CTOR) Receivables - Net (2025 - 2026) Analysis & Trends

Citius Oncology (CTOR) has 2 years of Receivables - Net data on file, last reported at $1.1 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Citius Oncology	58.02 Mn	58.02 Mn	1.34 Mn

Download Data